Mason Freeman - Net Worth and Insider Trading
Mason Freeman Net Worth
The estimated net worth of Mason Freeman is at least $0 dollars as of 2024-09-20. Mason Freeman is the Chief Medical Officer of CinCor Pharma Inc and owns about 0 shares of CinCor Pharma Inc (CINC) stock worth over $0. Details can be seen in Mason Freeman's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mason Freeman has not made any transactions after 2022-06-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Mason Freeman
Mason Freeman Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mason Freeman owns 3 companies in total, including scPharmaceuticals Inc (SCPH) , Crinetics Pharmaceuticals Inc (CRNX) , and CinCor Pharma Inc (CINC) .
Click here to see the complete history of Mason Freeman’s form 4 insider trades.
Insider Ownership Summary of Mason Freeman
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SCPH | scPharmaceuticals Inc | 2018-07-20 | director |
| CRNX | Crinetics Pharmaceuticals Inc | 2018-07-17 | director |
| CINC | CinCor Pharma Inc | 2022-06-10 | EVP Clinical Development |
Mason Freeman Latest Holdings Summary
Mason Freeman currently owns a total of 1 stock. Mason Freeman owns 0 shares of CinCor Pharma Inc (CINC) as of June 10, 2022, with a value of $0.
Latest Holdings of Mason Freeman
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CINC | CinCor Pharma Inc | 2022-06-10 | 0 | 29.06 | 0 |
Holding Weightings of Mason Freeman
Mason Freeman Form 4 Trading Tracker
According to the SEC Form 4 filings, Mason Freeman has made a total of 2 transactions in CinCor Pharma Inc (CINC) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in CinCor Pharma Inc is the sale of 6 shares on June 10, 2022, which brought Mason Freeman around $91.
Insider Trading History of Mason Freeman
- 1
Mason Freeman Trading Performance
GuruFocus tracks the stock performance after each of Mason Freeman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Mason Freeman is 22.44%. GuruFocus also compares Mason Freeman's trading performance to market benchmark return within the same time period. The performance of stocks bought by Mason Freeman within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Mason Freeman's insider trading performs compared to the benchmark.
Performance of Mason Freeman
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 50.59 | | | | | |
| Relative Return to S&P 500(%) | 56.84 | | | | | |
Mason Freeman Ownership Network
Mason Freeman Owned Company Details
What does scPharmaceuticals Inc do?
Who are the key executives at scPharmaceuticals Inc?
Mason Freeman is the director of scPharmaceuticals Inc. Other key executives at scPharmaceuticals Inc include 10 percent owner Orbimed Advisors Llc , 10 percent owner 5am Partners Iv, Llc , and director & President and CEO John H Tucker .
scPharmaceuticals Inc (SCPH) Insider Trades Summary
Over the past 18 months, Mason Freeman made no insider transaction in scPharmaceuticals Inc (SCPH). Other recent insider transactions involving scPharmaceuticals Inc (SCPH) include a net purchase of 500,000 shares made by Orbimed Advisors Llc ,
In summary, during the past 3 months, insiders sold 0 shares of scPharmaceuticals Inc (SCPH) in total and bought 500,000 shares, with a net purchase of 500,000 shares. During the past 18 months, 0 shares of scPharmaceuticals Inc (SCPH) were sold and 500,000 shares were bought by its insiders, resulting in a net purchase of 500,000 shares.
scPharmaceuticals Inc (SCPH)'s detailed insider trading history can be found in Insider Trading Tracker table.
scPharmaceuticals Inc Insider Transactions
Mason Freeman Mailing Address
Above is the net worth, insider trading, and ownership report for Mason Freeman. You might contact Mason Freeman via mailing address: C/o Crinetics Pharmaceuticals, Inc., 10222 Barnes Canyon Road, Bldg. #2, San Diego Ca 92121.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
